ArticleTranslational psychiatry2017
Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia.
Open access · goldAbstract read
In one paragraph
Article in Translational psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 7 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 7 pooled it
19.2field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
83 citing papers in PubMed, 7 syntheses or guidelines pooled it, 191 citations in OpenAlex.
- Genome-wide association analyses of borderline personality disorder identify 11 loci and highlight shared risk with mental and somatic disorders.Nature genetics · 2026Pooled it
- Psychological trauma as a transdiagnostic risk factor for mental disorder: an umbrella meta-analysis.European archives of psychiatry and clinical neuroscience · 2023Pooled it
- The impact of bipolar spectrum disorders on professional functioning: A systematic review.Frontiers in psychiatry · 2022Pooled it
- Genome-wide association study of panic disorder reveals genetic overlap with neuroticism and depression.Molecular psychiatry · 2021Pooled it
- Clinical Features, Neuropsychology and Neuroimaging in Bipolar and Borderline Personality Disorder: A Systematic Review of Cross-Diagnostic Studies.Frontiers in psychiatry · 2021Pooled it
- The Relationship between Maternal Personality Disorder and Early Birth Outcomes: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2020Pooled it
- Multivariate analysis of genome-wide data to identify potential pleiotropic genes for five major psychiatric disorders using MetaCCA.Journal of affective disorders · 2019Pooled it
- Genetic interconnections between personality-related phenotypes and psychiatric disorders.European archives of psychiatry and clinical neuroscience · 2026Article
- Article
- Assessment of neurotransmitter-related structural brain changes in borderline personality disorder: an MRI study.Scientific reports · 2026Article
- Shared and Distinct Time-Space Experiences Along the Psychotic-Affective Continuum.Schizophrenia bulletin · 2026Article
- The Regulatory Potential of Long Non-Coding RNAs in Bipolar Disorder.International journal of molecular sciences · 2026Review
- Affective Factors in the Co-Occurrence of Personality Disorders and Substance Use Disorders.Current addiction reports · 2026Review
- Research Review: What we have learned about early detection and intervention of borderline personality disorder.Journal of child psychology and psychiatry, and allied disciplines · 2025Review
- Developing Trace: A Transdiagnostic Screening Tool for Early Detection of a Pluripotent at-Risk Mental State.International journal of methods in psychiatric research · 2025Article
- Brain iron distribution in transdiagnostic mental health burden.PCN reports : psychiatry and clinical neurosciences · 2025Article
- Increased self-focus and diminished informativity: referential and structural properties of narrative speech production in borderline personality disorder.Borderline personality disorder and emotion dysregulation · 2025Article
- Symptom Overlap Between Depression and Borderline Personality Disorder: A Network Analysis.Personality and mental health · 2025Article
- Emerging functions of Plakophilin 4 in the control of cell contact dynamics.Cell communication and signaling : CCS · 2025Review
- Molecular Pathways, Neural Circuits and Emerging Therapies for Self-Injurious Behaviour.International journal of molecular sciences · 2025Review
23 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
157 authors at 20 institutions in 17 countries.
S H WittCentral Institute of Mental Health, Department of Genetic Epidemiology in Psychiatry, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
F StreitCentral Institute of Mental Health, Department of Genetic Epidemiology in Psychiatry, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
M JungkunzCentral Institute of Mental Health, Clinic of Psychosomatic and Psychotherapeutic Medicine, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
J FrankCentral Institute of Mental Health, Department of Genetic Epidemiology in Psychiatry, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
S AwasthiDepartment of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany.
C S ReinboldHuman Genomics Research Group, Department of Biomedicine, University of Basel, Basel, Switzerland.
J TreutleinCentral Institute of Mental Health, Department of Genetic Epidemiology in Psychiatry, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
F DegenhardtInstitute of Human Genetics, University of Bonn, Bonn, Germany.
A J ForstnerHuman Genomics Research Group, Department of Biomedicine, University of Basel, Basel, Switzerland.
S Heilmann-HeimbachInstitute of Human Genetics, University of Bonn, Bonn, Germany.
L DietlDepartment of Psychiatry, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
C E SchwarzeDepartment of Clinical Psychology and Psychotherapy, University of Heidelberg, Heidelberg, Germany.
D SchendelCentral Institute of Mental Health, Department of Genetic Epidemiology in Psychiatry, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
J StrohmaierCentral Institute of Mental Health, Department of Genetic Epidemiology in Psychiatry, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
A AbdellaouiDepartment of Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
R AdolfssonDepartment of Clinical Sciences, Psychiatry, Umeå University, Umeå, Sweden.
T M AirDiscipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia.
H AkilMolecular and Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, MI, USA.
M AldaDepartment of Psychiatry, Dalhousie University, Halifax, NS, Canada.
N Alliey-RodriguezDepartment of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, USA.
O A AndreassenDivision Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
G BabadjanovaInstitute of Pulmonology, Russian State Medical University, Moscow, Russian Federation.
N J BassDivision of Psychiatry, University College London, London, UK.
M BauerDepartment of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Dresden, Germany.
B T BauneDiscipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia.
F BellivierInserm, U1144, AP-HP, GH Saint-Louis, Département de Psychiatrie et de Médecine Addictologique, Paris, France.
S BergenDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
A BethellNational Center for Mental Health, Cardiff University, Cardiff, UK.
J M BiernackaHealth Sciences Research, Mayo Clinic, Rochester, MN, USA.
D H R BlackwoodDivision of Psychiatry, University of Edinburgh, Edinburgh, UK.
M P BoksUrain Center Rudolf Magnus, Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands.
D I BoomsmaDepartment of Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
A D BørglumDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
M Borrmann-HassenbachMedical and Quality Assurance, Clinics of Upper Bavaria, Munich, Germany.
P BrennanGenetic Epidemiology Group, International Agency for Research on Cancer, Lyon, France.
M BuddeDepartment of Psychiatry and Psychotherapy, University Medical Center Göttingen, Goettingen, Germany.
H N ButtenschønTranslational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
E M ByrneQueensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.
P CervantesDepartment of Psychiatry, McGill University, Montreal, QC, Canada.
T-K ClarkeDivision of Psychiatry, University of Edinburgh, Edinburgh, UK.
N CraddockDivision of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
C CruceanuDepartment of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.
D CurtisCentre for Psychiatry, Queen Mary University of London, London, UK.
P M CzerskiLaboratory of Psychiatric Genetics, Department of Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.
U DannlowskiDepartment of Psychiatry, University of Marburg, Marburg, Germany.
T DavisDiscipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia.
E J C de GeusDepartment of Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
A Di FlorioDivision of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
S DjurovicDepartment of Medical Genetics, Oslo University Hospital Ullevål, Oslo, Norway.
E DomeniciCentre for Integrative Biology, Università degli Studi di Trento, Trento, Italy.
H J EdenbergIndiana University School of Medicine, Department of Biochemistry and Molecular Biology, Indianapolis, IN, USA.
B EtainFaculté de Médecine, Université Paris Est, Créteil, France.
S B FischerHuman Genomics Research Group, Department of Biomedicine, University of Basel, Basel, Switzerland.
L FortyDivision of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
C FraserDivision of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
M A FryeDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
J M FullertonSchool of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.
K GadeDepartment of Psychiatry and Psychotherapy, University Medical Center Göttingen, Goettingen, Germany.
E S GershonDepartment of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, USA.
I GieglingDepartment of Psychiatry, University of Halle, Halle, Germany.
S D GordonGenetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
K Gordon-SmithDepartment of Psychological Medicine, University of Worcester, Worcester, UK.
H J GrabeDepartment of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
E K GreenSchool of Biomedical and Healthcare Sciences, Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK.
T A GreenwoodDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
M Grigoroiu-SerbanescuBiometric Psychiatric Genetics Research Unit, Alexandru Obregia Clinical Psychiatric Hospital, Bucharest, Romania.
J Guzman-ParraMental Health Department, Biomedicine Institute, University Regional Hospital, Málaga, Spain.
L S HallDivision of Psychiatry, University of Edinburgh, Edinburgh, UK.
M HamshereDivision of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
J HauserLaboratory of Psychiatric Genetics, Department of Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.
M HautzingerDepartment of Psychology, Eberhard Karls Universität Tübingen, Tubingen, Germany.
U HeilbronnerMedical Center of the University of Munich, Campus Innenstadt, Institute of Psychiatric Phenomics and Genomics (IPPG), Munich, Germany.
S HermsHuman Genomics Research Group, Department of Biomedicine, University of Basel, Basel, Switzerland.
S HitturlingappaDiscipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia.
P HoffmannHuman Genomics Research Group, Department of Biomedicine, University of Basel, Basel, Switzerland.
P HolmansDivision of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
J-J HottengaDepartment of Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
S JamainFaculté de Médecine, Université Paris Est, Créteil, France.
I JonesNational Center for Mental Health, Cardiff University, Cardiff, UK.
L A JonesDepartment of Psychological Medicine, University of Worcester, Worcester, UK.
A JuréusDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
R S KahnUniversity Medical Center Utrecht, Division of Neuroscience, Department of Psychiatry, Utrecht, The Netherlands.
J Kammerer-CierniochCenter of Psychiatry Weinsberg, Weinsberg, Germany.
G KirovDivision of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
S Kittel-SchneiderDepartment of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt am Main, Frankfurt am Main, Germany.
S KloiberCentre for Addiction and Mental Health, Toronto, ON, Canada.
S V KnottDepartment of Psychological Medicine, University of Worcester, Worcester, UK.
M KogevinasCenter for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
M LandénDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
M LeberClinic for Psychiatry and Psychotherapy, University Hospital Cologne, Cologne, Germany.
M LeboyerInserm U955, Translational Psychiatry Laboratory, AP-HP, DHU PePSY, Department of Psychiatry, Université Paris Est, Créteil, France.
Q S LiJanssen Research and Development, LLC, Neuroscience Therapeutic Area, Titusville, NJ, USA.
J LissowskaM. Sklodowska-Curie Cancer Center and Institute of Oncology, Cancer Epidemiology and Prevention, Warsaw, Poland.
S LucaeMax Planck Institute of Psychiatry, Munich, Germany.
N G MartinGenetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
F Mayoral-CleriesMental Health Department, Biomedicine Institute, University Regional Hospital, Málaga, Spain.
S L McElroyLindner Center of HOPE, Research Institute, Mason, OH, USA.
A M McIntoshDivision of Psychiatry, University of Edinburgh, Edinburgh, UK.
J D McKayGenetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon, France.
A McQuillinDivision of Psychiatry, University College London, London, UK.
S E MedlandGenetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
C M MiddeldorpDepartment of Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Y MilaneschiVU University Medical Center and GGZ inGeest, Department of Psychiatry, Amsterdam, The Netherlands.
P B MitchellSchool of Psychiatry, University of New South Wales, Sydney, NSW, Australia.
G W MontgomeryInstitute for Molecular Biology, University of Queensland, Brisbane, QLD, Australia.
G MorkenDepartment of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway.
O MorsRisskov, Psychosis Research Unit, Aarhus University Hospital, Aarhus, Denmark.
T W MühleisenResearch Center Juelich, Institute of Neuroscience and Medicine (INM-1), Juelich, Germany.
B Müller-MyhsokDepartment of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.
R M MyersHudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
C M NievergeltDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
J I NurnbergerDepartment of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA.
M C O'DonovanMRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
L M O LoohuisCenter for Neurobehavioral Genetics, University of California Los Angeles, Los Angeles, CA, USA.
R OphoffUniversity Medical Center Utrecht, Division of Brain Research, Utrecht, The Netherlands.
L OrucPsychiatry Clinic, Clinical Center University of Sarajevo, Sarajevo, Bosnia-Herzegovina.
M J OwenMRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
S A PacigaPfizer Global Research and Development, Human Genetics and Computational Biomedicine, Groton, CT, USA.
B W J H PenninxVU University Medical Center and GGZ inGeest, Department of Psychiatry, Amsterdam, The Netherlands.
A PerryDepartment of Psychological Medicine, University of Worcester, Worcester, UK.
A PfennigDepartment of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Dresden, Germany.
J B PotashDepartment of Psychiatry, University of Iowa, Iowa City, IA, USA.
M PreisigDepartment of Psychiatry, Psychiatric University Hospital of Lausanne, Lausanne, Switzerland.
A ReifDepartment of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt am Main, Frankfurt am Main, Germany.
F RivasMental Health Department, Biomedicine Institute, University Regional Hospital, Málaga, Spain.
G A RouleauDepartment of Neurology and Neurosurgery, Faculty of Medicine, McGill University, Montreal, QC, Canada.
P R SchofieldSchool of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.
T G SchulzeCentral Institute of Mental Health, Department of Genetic Epidemiology in Psychiatry, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
M SchwarzPsychiatric Center Nordbaden, Wiesloch, Germany.
L ScottCenter for Statistical Genetics, Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA.
G C B SinnamonSchool of Medicine and Dentistry, James Cook University, Townsville, QLD, Australia.
E A StahlBroad Institute of MIT and Harvard, Medical and Population Genetics, Cambridge, MA, USA.
J StraussCentre for Addiction and Mental Health, Toronto, ON, Canada.
G TureckiDepartment of Psychiatry, McGill University, Montreal, QC, Canada.
S Van der AuweraDepartment of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
H VedderPsychiatric Center Nordbaden, Wiesloch, Germany.
J B VincentCentre for Addiction and Mental Health, Molecular Neuropsychiatry and Development Laboratory, Toronto, ON, Canada.
G WillemsenDepartment of Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
C C WittDepartment of Anaesthesiology and Operative Intensive Care, University Hospital Mannheim, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany.
N R WrayQueensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.
H S XiPfizer Global Research and Development, Computational Sciences Center of Emphasis, Cambridge, MA, USA.
Bipolar Disorders Working Group of the Psychiatric Genomics Consortium
Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium
Schizophrenia Working Group of the Psychiatric Genomics Consortium
A TadicAGAPLESION Elisabethenstift gGmbh, Department of Psychiatry, Psychosomatics and Psychotherapy, Darmstadt, Germany.
N DahmenUniversity Medical Center, Department of Psychiatry and Psychotherapy, Mainz, Germany.
B H SchottDepartment of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany.
S CichonInstitute of Human Genetics, University of Bonn, Bonn, Germany.
M M NöthenInstitute of Human Genetics, University of Bonn, Bonn, Germany.
S RipkeDepartment of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany.
A MobascherUniversity Medical Center, Department of Psychiatry and Psychotherapy, Mainz, Germany.
D RujescuDepartment of Psychiatry, University of Halle, Halle, Germany.
K LiebUniversity Medical Center, Department of Psychiatry and Psychotherapy, Mainz, Germany.
S RoepkeDepartment of Psychiatry, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
C SchmahlCentral Institute of Mental Health, Clinic of Psychosomatic and Psychotherapeutic Medicine, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
M BohusCentral Institute of Mental Health, Institute for Psychiatric and Psychosomatic Psychotherapy (IPPP)/Psychosomatic Medicine and Psychotherapy, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
M RietschelCentral Institute of Mental Health, Department of Genetic Epidemiology in Psychiatry, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Cardiff University · GBUniversity of Bonn · DEVrije Universiteit Amsterdam · NLHeidelberg University · DECentral Institute of Mental Health · DECharité - Universitätsmedizin Berlin · DEMax Planck Institute of Psychiatry · DEUniversity of Adelaide · AUUniversity of Basel · CHUniversity of Worcester · GBQIMR Berghofer Medical Research Institute · AUUniversity Hospital Heidelberg · DEUniversity of Edinburgh · GBUniversity of Göttingen · DEUniversity of Queensland · AUAarhus University · DKBroad Institute · USCentre for Addiction and Mental Health · CACentre International de Recherche sur le Cancer · FRJohannes Gutenberg University Mainz · DE
Funding
Genomic Studies of Bipolar Disorder in a Large Cohort from The NetherlandsR01MH090553 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI OPHOFF, ROEL A · 2010 to 2014
$6.0M5/7 Psychiatric Genomics Consortium: Finding actionable variationU01MH109514 · NIMH · CARDIFF UNIVERSITY · PI O'DONOVAN, MICHAEL · 2016 to 2020
$2.9M3/7 Psychiatric Genomics Consortium: Finding actionable variationU01MH109536 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CHARNEY, ALEXANDER W, HUCKINS, LAURA MARIANNE · 2016 to 2020
$2.7MMedical Research Council G1000708NIMH NIH HHS R01 MH090553NIMH NIH HHS U01 MH109514NIMH NIH HHS U01 MH109536World Health Organization 001
Abstract
Borderline personality disorder (BOR) is determined by environmental and genetic factors, and characterized by affective instability and impulsivity, diagnostic symptoms also observed in manic phases of bipolar disorder (BIP). Up to 20% of BIP patients show comorbidity with BOR. This report describes the first case-control genome-wide association study (GWAS) of BOR, performed in one of the largest BOR patient samples worldwide. The focus of our analysis was (i) to detect genes and gene sets involved in BOR and (ii) to investigate the genetic overlap with BIP. As there is considerable genetic overlap between BIP, major depression (MDD) and schizophrenia (SCZ) and a high comorbidity of BOR and MDD, we also analyzed the genetic overlap of BOR with SCZ and MDD. GWAS, gene-based tests and gene-set analyses were performed in 998 BOR patients and 1545 controls. Linkage disequilibrium score regression was used to detect the genetic overlap between BOR and these disorders. Single marker analysis revealed no significant association after correction for multiple testing. Gene-based analysis yielded two significant genes: DPYD (P=4.42 × 10
Indexed as
AdolescentAdultAgedBipolar DisorderBorderline Personality DisorderCase-Control StudiesFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHumansMajor Depressive DisorderMaleMiddle AgedMultifactorial InheritanceSchizophrenia
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.